What The Study Did: The findings from this study that included more than 1,100 patients with prostate cancer found no statistically significant difference in the rates of 30-day mortality from any cause following COVID-19 infection among men receiving androgen deprivation therapy compared with those men who didn't receive that therapy.
Authors: Rana R. McKay, M.D., of the University of California, San Diego, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.34330)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.34330?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111221
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
JAMA Network Open